派林生物(000403.SZ)发布上半年业绩，归母净利润2.36亿元，下降27.89%

Group 1 - The core viewpoint of the article is that Palin Biotech (000403.SZ) reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] - The company's operating revenue for the first half of 2025 was 986 million yuan, a year-on-year decrease of 13.18% [1] - The net profit attributable to shareholders of the listed company was 236 million yuan, reflecting a year-on-year decline of 27.89% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 215 million yuan, which also decreased by 27.63% year-on-year [1] - The basic earnings per share for the company stood at 0.25 yuan [1]